ARAIX
Price
$77.63
Change
-$0.72 (-0.92%)
Updated
Feb 3 closing price
Net Assets
2.73B
VMVAX
Price
$96.91
Change
+$7.30 (+8.15%)
Updated
Feb 3 closing price
Net Assets
33.17B
Interact to see
Advertisement

ARAIX vs VMVAX

Header iconARAIX vs VMVAX Comparison
Open Charts ARAIX vs VMVAXBanner chart's image
Ariel Fund Institutional
Price$77.63
Change-$0.72 (-0.92%)
VolumeN/A
Net Assets2.73B
Vanguard Mid-Cap Value Index Admiral
Price$96.91
Change+$7.30 (+8.15%)
VolumeN/A
Net Assets33.17B
ARAIX vs VMVAX Comparison Chart in %
View a ticker or compare two or three
VS
ARAIX vs. VMVAX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAIX is a Hold and VMVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 33.2B vs. ARAIX (2.73B). VMVAX pays higher dividends than ARAIX: VMVAX (2.01) vs ARAIX (0.11). ARAIX was incepted earlier than VMVAX: ARAIX (14 years) vs VMVAX (14 years). ARAIX (0.69) is less costly to investors than VMVAX (0.07). VMVAX is a more actively managed with annual turnover of: 19.00 vs. ARAIX (17.00). VMVAX has a lower initial minimum investment than ARAIX: VMVAX (3000) vs ARAIX (1000000). VMVAX annual gain was more profitable for investors over the last year : 13.53 vs. ARAIX (6.50). VMVAX return over 5 years is better than : 52.71 vs. ARAIX (9.54).
ARAIXVMVAXARAIX / VMVAX
Total Expense Ratio0.690.07986%
Annual Report Gross Expense Ratio0.690.07986%
Fund Existence14 years14 years-
Gain YTD6.2485.509113%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets2.73B33.2B8%
Annual Yield % from dividends0.112.016%
Returns for 1 year6.5013.5348%
Returns for 3 years9.0829.3731%
Returns for 5 years9.5452.7118%
Returns for 10 years62.35142.8944%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ETNHX51.170.44
+0.87%
Eventide Healthcare & Life Sciences N
FGETX25.40N/A
N/A
Fidelity Advisor Glbl Capital Apprec M
JMCCX58.29-0.09
-0.15%
JPMorgan Mid Cap Equity C
AQGIX12.48-0.07
-0.56%
AQR Global Equity I
MSHNX12.87-0.28
-2.13%
Morgan Stanley Inst Permanence A